olmesartan has been researched along with Alloxan Diabetes in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (31.58) | 29.6817 |
| 2010's | 11 (57.89) | 24.3611 |
| 2020's | 2 (10.53) | 2.80 |
| Authors | Studies |
|---|---|
| Abo El-Nasr, NME; Hashad, IM; Saleh, DO | 1 |
| Abdelsalam, RM; Abo El-Nasr, NME; El-Abhar, HS; Mahmoud, SS; Nofal, SM; Safar, MM; Saleh, DO | 1 |
| Carvalho-Tavares, J; Castro-Faria Neto, H; Estato, V; Freitas, FS; Lessa, MA; Obadia, N; Reis, P; Tibiriçá, E | 1 |
| Goto, M; Hiramatsu, O; Kajiya, F; Ogasawara, Y; Shimokawa, H; Yada, T | 1 |
| Hosoya, M; Ohashi, J; Sawada, A; Shimokawa, H; Takaki, A | 1 |
| Iwamoto, Y; Maekawa, Y; Ohishi, M; Ohnishi, M; Rakugi, H; Shiota, A; Takeda, M; Tatara, Y; Yamamoto, K | 1 |
| Chen, JF; Li, HW; Song, HF; Sun, NL | 1 |
| Baba, M; Kojima, K; Sugimoto, K; Yasujima, M | 1 |
| Imada, T; Iwasaka, T; Jo, F; Jo, H; Kosaki, A; Kusabe, M; Morimoto, S; Morita, T; Nakahigashi, M; Nishikawa, M; Someya, K; Toyoda, N | 1 |
| Arumugam, S; Giridharan, VV; Kodama, M; Lakshmanan, AP; Meilei, H; Sari, FR; Soetikno, V; Sukumaran, V; Suzuki, K; Thandavarayan, RA; Watanabe, K | 1 |
| Akarte, AS; Gandhi, S; Srinivasan, BP | 1 |
| Aksak, S; Albayrak, A; Albayrak, F; Gundogdu, C; Halici, Z; Karakus, E; Kiki, I; Ozturk, B; Polat, B; Sipal, S | 1 |
| Fukumoto, Y; Hosoya, M; Nakajima, S; Noda, K; Ohashi, J; Shimokawa, H | 1 |
| Arakawa, N; Fujimori, I; Inoue, T; Nakamura, H; Shimakawa, E; Shimizu, Y; Toyoshi, T; Yokoyama, T; Yoshigae, Y | 1 |
| Abe, H; Arai, H; Doi, T; Fukatsu, A; Iehara, N; Kanamori, H; Kita, T; Matsubara, T; Mima, A; Nagai, K; Sumi, E; Takahashi, T | 1 |
| Hirata, A; Igarashi, M; Kadomoto-Antsuki, Y; Nozaki, H; Tominaga, M | 1 |
| Danser, AH; Krop, M; van Esch, JH | 1 |
| Abe, H; Arai, H; Araki, M; Doi, T; Fukatsu, A; Iehara, N; Kanamori, H; Kita, T; Matsubara, T; Matsuura, M; Mima, A; Nagai, K; Takahashi, T; Tamura, Y; Tominaga, T; Torikoshi, K | 1 |
| Kang, JJ; Meer, EJ; Peti-Peterdi, J; Sipos, A; Toma, I; Vargas, SL | 1 |
19 other study(ies) available for olmesartan and Alloxan Diabetes
| Article | Year |
|---|---|
Role of olmesartan in ameliorating diabetic nephropathy in rats by targeting the AGE/PKC, TLR4/P38-MAPK and SIRT-1 autophagic signaling pathways.
Topics: Animals; Diabetes Complications; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Fructose; Imidazoles; Kidney; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Rats; Signal Transduction; Sirtuins; Streptozocin; Tetrazoles; Toll-Like Receptor 4 | 2022 |
Olmesartan attenuates type 2 diabetes-associated liver injury: Cross-talk of AGE/RAGE/JNK, STAT3/SCOS3 and RAS signaling pathways.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Blood Glucose; Diabetes Complications; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glycation End Products, Advanced; Hypoglycemic Agents; Imidazoles; Insulin; Insulin Resistance; JNK Mitogen-Activated Protein Kinases; Liver; Liver Diseases; Male; Rats, Wistar; Receptor for Advanced Glycation End Products; Renin-Angiotensin System; Signal Transduction; STAT3 Transcription Factor; Tetrazoles | 2020 |
Blockade of the renin-angiotensin system improves cerebral microcirculatory perfusion in diabetic hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arterial Pressure; Blood Glucose; Brain; Capillaries; Cerebrovascular Circulation; Cerebrovascular Disorders; Coronary Circulation; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Diet, High-Fat; Enalapril; Heart Ventricles; Hypertension; Imidazoles; Insulin; Leukocyte Rolling; Male; Microcirculation; Microscopy, Fluorescence; Microscopy, Video; Muscle, Skeletal; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin-Angiotensin System; Streptozocin; Tetrazoles | 2013 |
Role of endogenous hydrogen peroxide during angiotensin type 1 receptor blockers administration in pacing-induced metabolic coronary vasodilatation in dogs in vivo.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Alloxan; Angiotensin II Type 1 Receptor Blockers; Animals; Biological Factors; Cardiac Pacing, Artificial; Catalase; Coronary Vessels; Deoxyguanosine; Diabetes Mellitus, Experimental; Dogs; Female; Hydrogen Peroxide; Ibuprofen; Imidazoles; Infusions, Intravenous; Male; Microcirculation; Myocardium; omega-N-Methylarginine; Superoxide Dismutase; Tetrazoles; Vasodilation | 2013 |
Combination therapy with olmesartan and azelnidipine improves EDHF-mediated responses in diabetic apolipoprotein E-deficient mice.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Apolipoproteins E; Azetidinecarboxylic Acid; Biological Factors; Calcium Channel Blockers; Diabetes Mellitus, Experimental; Dihydropyridines; Disease Models, Animal; Drug Therapy, Combination; Endothelium, Vascular; Imidazoles; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide Synthase Type III; Proto-Oncogene Proteins c-akt; Signal Transduction; Streptozocin; Tetrazoles; Vasodilation | 2010 |
Loss of ACE2 accelerates time-dependent glomerular and tubulointerstitial damage in streptozotocin-induced diabetic mice.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Imidazoles; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nephrons; Peptidyl-Dipeptidase A; Phenotype; Receptor, Angiotensin, Type 1; Tetrazoles | 2010 |
Effects of angiotensin II receptor antagonist olmesartan on renal hemodynamic variables and vascular structural properties in streptozotocin-induced diabetic rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Hemodynamics; Imidazoles; Kidney; Male; Organ Size; Rats; Rats, Wistar; Tetrazoles | 2011 |
Olmesartan ameliorates peripheral nerve dysfunction in Zucker diabetic fatty rats.
Topics: Adipokines; Animals; Blood Glucose; Blotting, Western; Body Weight; Diabetes Mellitus, Experimental; Fluorescent Antibody Technique; Ganglia, Spinal; Imidazoles; Insulin; Lipids; Male; Mitogen-Activated Protein Kinases; Peripheral Nerves; Phosphorylation; Rats; Rats, Zucker; Receptor, Insulin; Tetrazoles | 2011 |
Olmesartan induces renoprotective effects by stimulating angiotensin type 2 receptors and reducing oxidative stress in diabetic nephropathy.
Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Imidazoles; Male; Mice; Oxidative Stress; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles | 2011 |
Modulation of AT-1R/MAPK cascade by an olmesartan treatment attenuates diabetic nephropathy in streptozotocin-induced diabetic mice.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Apoptosis; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme Activation; Gene Expression; Imidazoles; Intracellular Signaling Peptides and Proteins; Kidney; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Peptidyl-Dipeptidase A; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Tetrazoles | 2012 |
Effective blockade of RAAS by combination of aliskiren and olmesartan improves glucose homeostasis, glomerular filtration rate along with renal variables in streptozotocin induced diabetic rats.
Topics: Amides; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Glucose; Diabetes Mellitus, Experimental; Drug Therapy, Combination; Fumarates; Glomerular Filtration Rate; Glucose Transporter Type 2; Glucose Transporter Type 4; Humans; Imidazoles; Insulin; Kidney; Liver; Muscle, Skeletal; Rats; Rats, Wistar; Renin-Angiotensin System; Serum Albumin; Tetrazoles; Time Factors | 2012 |
Comparative study of three angiotensin II type 1 receptor antagonists in preventing liver fibrosis in diabetic rats: stereology, histopathology, and electron microscopy.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Diabetes Mellitus, Experimental; Imidazoles; Liver Cirrhosis; Losartan; Male; Microscopy, Electron; Rats; Tetrazoles; Valine; Valsartan | 2012 |
Anti-atherogenic effects of the combination therapy with olmesartan and azelnidipine in diabetic apolipoprotein E-deficient mice.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Aorta, Thoracic; Apolipoproteins E; Atherosclerosis; Azetidinecarboxylic Acid; Azo Compounds; Blood Pressure; Body Weight; Calcium Channel Blockers; Coronary Vessels; Diabetes Mellitus, Experimental; Dihydropyridines; Drug Therapy, Combination; Imidazoles; Macrophages; Male; Mice; Mice, Inbred C57BL; Models, Biological; Myocytes, Cardiac; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphorylation; Systole; Tetrazoles | 2012 |
Pharmacological and pharmacokinetic study of olmesartan medoxomil in animal diabetic retinopathy models.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Area Under Curve; Benzimidazoles; Biphenyl Compounds; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Disease Models, Animal; Dose-Response Relationship, Drug; Electroretinography; Glycated Hemoglobin; Heart Rate; Hypertension; Hypoxia; Imidazoles; Male; Olmesartan Medoxomil; Oxygen; Rats; Rats, Inbred SHR; Retinal Neovascularization; Tetrazoles | 2005 |
Angiotensin II-dependent Src and Smad1 signaling pathway is crucial for the development of diabetic nephropathy.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Butadienes; Cell Line; Collagen Type IV; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Expression; Glomerular Mesangium; Imidazoles; Male; Mesangial Cells; Nitriles; Phosphorylation; Pyrimidines; Rats; Rats, Sprague-Dawley; RNA, Small Interfering; Signal Transduction; Smad1 Protein; src-Family Kinases; Tetrazoles | 2006 |
Role of angiotensin II type-1 and type-2 receptors on vascular smooth muscle cell growth and glucose metabolism in diabetic rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Aorta; Blood Glucose; Cells, Cultured; Deoxyglucose; Diabetes Mellitus, Experimental; DNA Replication; Imidazoles; Male; Muscle, Smooth, Vascular; Nuclear Proteins; Obesity; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles | 2007 |
Letter by Krop et al regarding article, "Role of p90 ribosomal S6 kinase-mediated prorenin-converting enzyme in ischemic and diabetic myocardium".
Topics: Angiotensin II; Angiotensinogen; Animals; Anti-Arrhythmia Agents; Buffers; Captopril; Diabetes Complications; Diabetes Mellitus, Experimental; Diffusion; Free Radical Scavengers; Imidazoles; Kallikreins; Mice; Mice, Transgenic; Myocardial Ischemia; Myocardium; Perfusion; Rats; Renin-Angiotensin System; Ribosomal Protein S6 Kinases, 90-kDa; Species Specificity; Tetrazoles | 2006 |
Urinary Smad1 is a novel marker to predict later onset of mesangial matrix expansion in diabetic nephropathy.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Biomarkers; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glomerular Mesangium; Imidazoles; Kidney; Male; Mice; Mice, Inbred C57BL; Rats; Rats, Sprague-Dawley; Smad1 Protein; Tetrazoles | 2008 |
The collecting duct is the major source of prorenin in diabetes.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cell Division; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Hypertension, Renal; Imidazoles; Immunohistochemistry; Juxtaglomerular Apparatus; Kidney Tubules, Collecting; Microscopy, Fluorescence; Quinacrine; Rats; Rats, Wistar; Renin; Tetrazoles; Trypsin; Vasoconstrictor Agents | 2008 |